Friday, June 13, 2025

 

Leading scientists: Trees and tech needed for carbon removal to help meet the 2C goal of the Paris agreement



Analysis shows high-tech and natural approaches to carbon removal complement—not compete with—one another and race to invest solely in novel approaches risks sidelining natural methods — which are already proven, low-cost and deliver multiple benefits.



Climate Focus





 Researchers released a peer-reviewed analysis in the academic journal Climate Policy today arguing that the urgent work of removing excess carbon from the atmosphere — known as carbon dioxide removal (CDR) — can’t just rely on complex, untested techniques to capture carbon dioxide (CO2) and inject it deep underground or pump it into the ocean. Rather, they show that nature-based solutions, which include restoring forests and other ecosystems that capture atmospheric CO2 using the ancient biochemical process of photosynthesis and store organic carbon in plants and soil, are also necessary for achieving global climate goals.

“We must rapidly reduce the production of new greenhouse gas emissions worldwide. At the same time, we must also remove and store excess carbon already polluting the atmosphere. In recent years, innovative high-tech CDR companies have introduced promising solutions for capturing carbon. However, these solutions are still in research and development stages, and they are not yet proven at the scale needed,” said Charlotte Streck, a professor at the University of Potsdam, the founder of Climate Focus and the lead author of the Climate Policy journal analysis, “Considering durability in carbon dioxide removal strategies for climate change mitigation.”

“At the same time, it’s well established that forests and other ecosystems are effective at storing carbon — while also providing clean air and water, safeguarding biodiversity and keeping the planet cool. We must embrace both high-tech and natural methods of CDR to succeed,” she said.

Countries and companies have embraced CDR, which was written into the Paris climate agreement, as a key strategy for fulfilling their climate goals and net zero commitments. It’s estimated that companies will invest some $250 billion in CDR by 2050, most of which will go to high-tech concepts that aren’t yet operational.

Nature and tech CDR are often pitted against each other. In those comparisons, nature CDR is referred to as “temporary” and tech CDR as “permanent.” Such binary classification implies the necessity of giving priority to tech over nature. However, creating such false choice does not help as available CDR strategies are all contributing to climate change mitigation, but differ in their risk profile, short- and long-term benefits. While tech CDR is more durable, nature CDR is tested, can be deployed now and can yield benefits for nature and people.

“Nature-based and engineered CDR can be deployed synergistically, including through investment portfolios that balance the conditions of feasibility, durability, and sustainability,” said Matthew Brander, professor of carbon accounting at the University of Edinburgh Business School. “Engineered novel CDR methods offer higher durability and lower reversal risks. However, conventional nature-based CDR methods that rely on storing carbon in vegetation and soil are the most immediately deployable methods at scale, and costs are comparatively low. It’s clear that high-tech and natural CDR methods can complement—not compete with—one another.”

The authors demonstrate that a balanced, comprehensive approach to investments in all forms of CDR offers the best prospect of meeting the long-term temperature goal of the Paris Agreement in the context of sustainable development.

What is CDR?

The authors of the authoritative Intergovernmental Panel on Climate Change (IPCC) define CDR as human "activities removing carbon dioxide (CO2) from the atmosphere and durably storing it in geological, terrestrial or ocean reservoirs, or in products."

CDR is classified according to how it captures carbon (for example, through photosynthesis or inorganic chemistry); where the carbon is stored (for example, land or sea); and the way in which it is stored, which can include plants and trees, soil, deep underground rock formations, minerals and the ocean floor.

The most successful CDR methods demonstrate readiness, feasibility, and the ability to remove a large amount of carbon without delay; sustainability, including the delivery of social and environmental benefits; and the durability of storage over the long term. Currently, no single CDR technique optimizes all three of these conditions and can sustain them over long periods of time.

“Engineered CDR is extremely expensive and will require huge amounts of cheap renewable energy, along with years of investment in research and development, before it’s ready to scale.” said Peter Ellis, the global director of natural climate solutions science at The Nature Conservancy. “In contrast, nature-based CDR is cheap and powered by photosynthesis, which has been in research and development in efficient self-replicating prototypes called plants for 3 billion years.”

The risk that stored carbon is released back into the atmosphere (e.g., through hazards, fire, pests or logging) is a key consideration in the CDR debate. Plans to store carbon in rocks, for example, are risky early on, before the carbon successfully hardens into minerals (mineralization). Over time, however, the risk of this CDR approach failing is significantly reduced. At the same time, natural approaches to CDR face different types and levels of risk over time. Not all newly planted ecosystems, for example, survive, and, even after these ecosystems are successfully established, they are vulnerable to unexpected human activities or the impacts of climate change, including fire, which releases carbon stored in wood back into the atmosphere.

“Policymakers and investors should encourage a balanced, comprehensive approach to investments in both nature- and tech-based CDR,” said Streck. “A balanced portfolio mitigates against risks of any one strategy and is most likely to make meaningful contributions toward achieving Paris Agreement goals.”

 

Researchers build a better dental implant



Preclinical study demonstrates a new ‘smart’ implant and minimally invasive surgery to better retain feel and function of natural teeth




Tufts University

Tufts researchers working on a smart dental implant 

image: 

From left to right: Study co-authors Subhashis Ghosh, Jake Jinkun Chen, and Siddhartha Das in Chen’s lab at Tufts’ Biomedical Research and Public Health Building.

view more 

Credit: Jenna Schad/Tufts University




Each year, millions of people in the U.S. get dental implants as a long-term, natural-looking fix for missing teeth. But traditional implants don’t fully mimic real teeth.

Researchers from Tufts University School of Dental Medicine and Tufts University School of Medicine recently described a new approach to dental implants that that could better replicate how natural teeth feel and function. Their study, published in Scientific Reportsshows early success with both a “smart” implant and a new gentler surgical technique in rodents.  

“Natural teeth connect to the jawbone through soft tissue rich in nerves, which help sense pressure and texture and guide how we chew and speak. Implants lack that sensory feedback,” says Jake Jinkun Chen, DI09, a professor of periodontology and director of the Division of Oral Biology at the School of Dental Medicine and the senior author on the study.

Traditional dental implants use a titanium post that fuses directly to the jawbone to support a ceramic crown, and the surgery often cuts or damages nearby nerves. To tie these inert pieces of metal into the body’s sensory system, the Tufts team developed an implant wrapped in an innovative biodegradable coating. This coating contains stem cells and a special protein that helps them multiply and turn into nerve tissue. As the coating dissolves during the healing process, it releases the stem cells and protein, fueling the growth of new nerve tissue around the implant.

The coating also contains tiny, rubbery particles that act like memory foam. Compressed so that the implant is smaller than the missing tooth when it’s first inserted, these nanofibers gently expand once in place until the implant snugly fits the socket. This allows for a new minimally invasive procedure that preserves existing nerve endings in the tissue around the implant.

“This new implant and minimally invasive technique should help reconnect nerves, allowing the implant to ‘talk’ to the brain much like a real tooth,” explains Chen. “This breakthrough also could transform other types of bone implants, like those used in hip replacements or fracture repair.”

Six weeks after surgery, the implants stayed firmly in place in rats, with no signs of inflammation or rejection. “Imaging revealed a distinct space between the implant and the bone, suggesting that the implant had been integrated through soft tissue rather than the traditional fusion with the bone,” says Chen. This may restore the nerves around it.

The research was conducted by Chen and School of Dental Medicine faculty Qisheng Tu and Zoe Zhu, as well as postdoctoral scholars Siddhartha Das (lead author) and Subhashis Ghosh at Tufts University School of Medicine.

These initial results are promising, but it will take more studies and time—for example, research in larger animal models to look at outcomes, including safety and efficacy—before trials can begin in human volunteers.

The researchers’ next step will be a preclinical study to see if brain activity confirms that the new nerves surrounding the prototype implant indeed relay sensory information.

Citation: Research reported in this article was supported by the National Institutes of Health under award numbers RO1DK131444, R01DE030074, R01DE025681, and R01DE032006. Complete information on authors, funders, methodology, limitations, and conflicts of interest is available in the published paper. 

Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.  

 

BathMat clinical trial launches across NHS Trusts to ease staff workload and boost patient care



Clinical trial of inflatable patient repositioning pillow device begins




University of Bath

The BathMat inflatable prone repositioning device, being demonstrated with a healthy volunteer 

image: 

The BathMat inflatable prone repositioning device, being demonstrated with a healthy volunteer

view more 

Credit: University of Bath




University of Bath press release

BathMat trial launches across NHS Trusts to ease staff workload and boost patient care

Clinical trial of inflatable patient repositioning pillow device begins

Clinical trials of an innovative inflatable pillow designed to make moving intensive care unit (ICU) patients safer, faster, and less labour-intensive for NHS staff have begun in Bath.

Co-developed by researchers at the University of Bath and clinicians at the Royal United Hospitals Bath NHS Foundation Trust (RUH), and funded by the National Institute for Health and Care Research (NIHR), the Inflatable Prone Repositioning Device – known as the ‘BathMat’ – is a flat balloon-like pillow that can be inflated in sections, and is the first medical device of its kind.

The device was conceived to tackle a major challenge in ICUs: repositioning sedated, ventilated patients in the prone (face-down) position – often among the most critically ill – to avoid pressure injuries and improve oxygenation. Placed under a sedated patient it can gently lift their chest and hips, helping ward staff safely and quickly reposition their head and arms.

The assistance provided by the BathMat has the added benefit of reducing the number of staff needed to move a patient from five to two.

Dr Alexander Lunt, Senior Lecturer in Mechanical Engineering at the University of Bath and the project’s Principal Investigator, said: “Moving critically ill patients is a significant challenge on intensive care wards worldwide. We are pleased to be using our engineering expertise to work toward a better solution to the issue, and to further build our close partnership with our partners at our local NHS Trust, the RUH.”

Trials in four major hospitals

Clinical trials to evaluate the BathMat’s effectiveness began at the RUH in late May. The trials will expand to include Southmead Hospital (North Bristol NHS Trust), Wythenshawe Hospital (Manchester University NHS Foundation Trust), and Derriford Hospital (University Hospitals Plymouth NHS Trust) in the coming weeks.

Aiming to recruit 30 patients across four NHS ICU sites, the trials are backed by a 14-month funding award from the NIHR. Several key outcomes will be measured, including reductions in staff time required for repositioning patients treated lying on their front (prone), improvements in patient healthcare outcomes such as pressure sore prevention, device safety and cost-effectiveness.

Widespread Enthusiasm from Healthcare Staff

Training sessions across the trial sites were met with overwhelmingly positive feedback. Hundreds of ICU staff have now been trained, with many describing the BathMat as a “no brainer” innovation.

Dr Jerome Condry, Chief Investigator and Research Fellow at the Royal United Hospitals Bath NHS Foundation Trust, said: "We’re seeing real enthusiasm from ICU teams who recognise the potential our device has to making repositioning proned patients easier and safer for everyone involved. We aim to have a big impact on both patient safety and team wellbeing."

Dr Lunt added: "We've already had other trusts reach out asking how they can access the device as they see the value it brings immediately."

Commercialisation and Next Steps

With regulatory approvals in place, the team is now turning its attention to commercialisation. Interest from investors is growing, and efforts are underway to develop a pressure-sensing version of the device that will automatically detect and adjust for pressure hotspots in real time.

Once all trial data is collected and analysed by health economics and statistics experts at the University of Bath, the team will publish the results and begin scaling up to reach more NHS stakeholders and manufacturers. The route to market is being actively developed in partnership with the University’s innovation and research commercialisation teams.

Call for collaborators

The research team welcomes expressions of interest from other NHS trusts or international partners who wish to take part in future trials or demonstrations. Conferences and showcase events are scheduled for 2026 where preliminary results and the next-generation version of the BathMat will be unveiled.

For more information and media resources, visit bathmatmedical.com.

  

HeatiodThe 'BathMat' inflatable prone repositioning device

Credit

University of Bath

ENDS

 

Images and video are available at: https://tinyurl.com/yc4pczwm

For more information or to request interviews, contact:

Will McManus, University of Bath: wem25@bath.ac.uk / +44(0)1225 385 798

Matthew Smith, RUH: matthew.smith38@nhs.net

The University of Bath

The University of Bath is one of the UK's leading universities, with a reputation for high-impact research, excellence in education, student experience and graduate prospects. 

We are ranked in the top 10 of all of the UK’s major university guides. We are also ranked among the world’s top 10% of universities, placing 150th in the QS World University Rankings 2025. Bath was rated in the world’s top 10 universities for sport in the QS World University Rankings by Subject 2024.

Research from Bath is helping to change the world for the better. Across the University’s three Faculties and School of Management, our research is making an impact in society, leading to low-carbon living, positive digital futures, and improved health and wellbeing. Find out all about our Research with Impact: https://www.bath.ac.uk/campaigns/research-with-impact/

 

About the NIHR

The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:

  • Funding high quality, timely research that benefits the NHS, public health and social care;
  • Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
  • Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
  • Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
  • Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
  • Funding applied global health research and training to meet the needs of the poorest people in low and middle income countries.

NIHR is funded by the Department of Health and Social Care. Its work in low and middle income countries is principally funded through UK international development funding from the UK government.

 

 

New study from landmark trial suggests avocados may play a role in sleep, a key factor in cardiovascular health



Hass Avocado Board
Heart-Healthy Grilled Shrimp Avocado Veggie Skewers 

image: 

New research suggests that eating one avocado a day may positively impact sleep.

view more 

Credit: Image courtesy of Avocados - Love One Today.




MISSION VIEJO, Calif. (June 11, 2025) – A new study suggests that eating one avocado a day may positively impact sleep. Science now confirms sleep is as important for good health as nutrition and exercise. In a secondary analysis of the largest randomized controlled trial on avocados to date, researchers found adults who consumed one avocado daily for six months reported better sleep compared to those who ate fewer than two avocados per month.

As, per the CDC, getting enough sleep can help lower the risk factors for heart disease, these findings add to a growing body of evidence supporting avocados as a heart-healthy food and mark the first time avocado consumption has been associated with sleep. The American Heart Association (AHA) recognizes healthy sleep duration as one of eight health factors that, when optimized, can promote ideal cardiovascular health.

“Sleep is emerging as a key lifestyle factor in heart health, and this study invites us to consider how nutrition—and foods like avocado—can play a role in improving it,” said Dr. Kristina Petersen, study author and associate professor of nutritional sciences at Penn State University. “Cardiovascular health is influenced by many factors, and while no single food is a silver bullet, some—like avocados—offer a range of nutrients that support multiple aspects of heart health. This is an encouraging step in expanding the science around avocados and the potential benefits of consumption.”

Supported by the Avocado Nutrition Center, this study involved 969 racially and ethnically diverse American adults with elevated waist circumference, a cardiovascular risk factor that affects nearly 60% of U.S. adults. Participants were randomized to either consume one avocado per day or minimal avocado intake (less than two avocados per month) while continuing their usual diet for six months.

Cardiovascular health was assessed using the AHA’s Life’s Essential 8TM, a framework used by healthcare professionals as well as individuals to better understand and reduce risk factors. This tool identifies diet quality, physical activity, nicotine exposure, sleep, body weight, blood pressure, blood lipids, and blood glucose as leading behaviors and factors that when improved, can lead to better health outcomes.  

Daily avocado intake was associated with improved diet quality (measured by the Healthy Eating Index 2015), blood lipids (modest reductions in LDL-C and total cholesterol levels) and sleep health (increased self-reported sleep duration). No significant effects were found for the other Life’s Essential 8 components.

Though the study was not originally designed to examine sleep as a primary outcome, the results offer an exciting direction for future research with more rigorous methodology and tools to better understand the potential for how the nutrients in avocados may support aspects of cardiovascular health. There are several strengths to this study design, but the findings are not conclusive and cannot be generalized to all populations.

Avocados have the following nutrients per serving (1/3 medium avocado) that may play a role in sleep:  

  • Tryptophan – 13mg, precursor to melatonin which plays a role in regulating sleep
  • Folate – 45 mcg (10% DV), involved in the production of melatonin  
  • Magnesium – 15mg (4% DV), involved in muscle contraction and relaxation 

Additionally, the combination of fiber and monounsaturated fats in avocados contributes to their beneficial impact on cardiovascular health.

  • Fiber – 3g (11% DV), one-third of the fiber in avocado is soluble fiber, which prevents the digestive tract from absorbing cholesterol and reduces the risk of heart disease
  • Monounsaturated fat – 5g, can help reduce LDL cholesterol levels, which can lower the risk of heart disease and stroke

To help healthcare providers and other experts encourage healthy dietary habits that incorporate avocado goodness and further the food is medicine movement, a free cookbook, Heart-Healthy Recipes Featuring Avocados, is available here.

About Avocados – Love One Today®

Avocados – Love One Today® is a leading source of the healthiest reasons and tastiest ways to enjoy fresh avocados. A science-based resource, it provides facts about fresh avocados in relevant and credible ways to help make it easy for health professionals and consumers to learn more about the nutritional benefits of fresh avocados and ways to include them in everyday menus. Visit www.LoveOneToday.com for avocado nutrition, recipes, and tips.

# # #

Media Contact

Vickie Fite

vickie.fite@mslgroup.com

310-264-6966